Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Opexa Therapeutics has priced a public offering of 3.5 million shares of common stock at a price to the public of $2 per share and 3.5 million series E warrants to purchase shares of common stock exercisable at $2 per share at a price of $0.15 per warrant.
Subscribe to our email newsletter
The company has granted a 30-day option to the underwriters to purchase up to an additional 15% of the offering to cover over-allotments. The company expects to receive approximately $7.5 million (approximately $8.7 million if the underwriter’s over-allotment option is exercised in full) in gross proceeds from the offering, which is subject to closing conditions.